Salisbury Foundation Trust

FOI_4651

Internal Reference Number: FOI_4651

Date Request Received: 12/10/2018 11:42:31

Date Request Replied To: 22/10/2018 09:19:16

This response was sent via: By Email

Request Summary: Pharmacy - unlicensed medicines

Request Category: Companies






 
Question Number 1:
Does your Trust have a policy on the use of unlicensed medicines? Please Answer Yes or No.

If yes, please provide a copy of the policy and all other relevant documentation
 
Answer To Question 1:
Please see attachment. FOI 4651.docx
 
Question Number 2:
Does your Trust have a policy or protocol on obtaining informed consent from patients when an unlicensed medicine is used? Please answer Yes or No.

If yes, please provide copies of all relevant documentation including copies of template informed consent materials used to consent patients where an unlicensed medicine is to be administered
 
Answer To Question 2:
Please see attachment on question 1.
 
Question Number 3:
Please state which Board level job role(s) is (are) responsible for patient safety and consenting.
 
Answer To Question 3:
Please see attachment on question 1.
 
Question Number 4:
Does your Trust have, or intend to introduce, a policy that makes compounded bevacizumab routinely available to treat wet age-related macular degeneration?

If yes please supply a copy of your policy
 
Answer To Question 4:
Please see attachment on question 1.
 
Question Number 5:
Does your Trust currently have a wholly NHS owned pharmacy with an aseptic unit for compounding/aliquotting medicines? Please answer Yes or NO.

If yes, is this NHS pharmacy the same legal entity as that of your hospital Trust?
 
Answer To Question 5:
Please see attachment on question 1.
 
Question Number 6:
Does your Trust currently host on its premises a privately owned pharmacy with an aseptic unit for compounding/aliquotting medicines? Please answer Yes or NO. If yes, please provide details of the third party provider of your pharmacy services.
 
Answer To Question 6:
Please see attachment on question 1.
 
Question Number 7:
Over the past two years has your Trust, on more than one occasion, used compounded Avastin (bevacizumab) for ophthalmic use? Please answer Yes or No.
 
Answer To Question 7:
Please see attachment on question 1.
 
Question Number 8:
If you answered yes to Q5 or Q6:

Is the pharmacy referred to above in Q5 or Q 6 currently providing, or potentially able to provide, compounded Avastin (bevacizumab) for ophthalmic use? Please answer Yes or No
 
Answer To Question 8:
Please see attachment on question 1.
 
Question Number 9:
If you answered yes to Q5 or Q6:

Does the pharmacy referred to above in Q5 or Q6 currently hold an MHRA license for the manufacture of specials? Please answer Yes or No
 
Answer To Question 9:
Please see attachment on question 1.
 
Question Number 10:
If you answered yes to Q5 or Q6 but no to Q9:

When was the pharmacy referred to above in answer to Q5 or Q6 last inspected by the CQC?
 
Answer To Question 10:
Please see attachment on question 1.
 
Question Number 11:
If you answered no to questions Q5 or Q6 above, but yes to question Q7:

Please provide information regarding from whom your Trust has or obtained/purchased compounded Avastin (bevacizumab). If you cannot provide the name of any commercial supplier, please provide as much information as possible.
 
Answer To Question 11:
Please see attachment on question 1.
Please see attachments:
FOI 4651.docx
 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Salisbury NHS Foundation Trust, Salisbury District Hospital, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2021 Salisbury NHS Foundation Trust
Trust Values